Home Tags Placebo

Tag: placebo

Acadia Pharmaceuticals (ACAD) Stock: Here’s What You Need To Know!

Acadia Pharmaceuticals (NASDAQ:ACAD) On Monday, Acadia Pharmaceuticals announced that it had initiated a phase 2 trial in patients with Alzheimer's Disease Agitation. Once again ACAD...

Sarepta Therapeutics (SRPT) Stock: Here’s What You Need To Know

Sarepta Therapeutics (NASDAQ:SRPT) On Monday, Sarepta's stock closed the day up 73.85% after the company announced that the FDA had given its drug Eteplirsen FDA...

Seres (MCRB) Stock: Here’s What You Need To Know

Seres Therapeutics (NASDAQ:MCRB) On Friday, Seres Therapeutics stock plummeted by 70% after the company reported that it had failed mid-stage trial in patients with Clostridium...

Biotech Stock News (SRPT) (BMRN) (ACAD)

Sarepta Therapeutics (NASDAQ:SRPT) On Monday April 25, 2016 Sarepta Therapeutics had an FDA advisory panel shoot down its drug Eteplirsen, used to treat patients with...

Biotech Stock News (RXII) (SRPT)

Rxi Pharmaceuticals (NASDAQ:RXII) On Tuesday April 19, 2016 Rxi Pharmaceuticals announced that it would present pre-clinical data at a medical conference, known as 2016 ARVO...

Biotech Stock News (ATHX) (FLXN)

Athersys (NASDAQ:ATHX) In after-hours trade on February 18, 2016 shares of Athersys were up 21% after the company announced that it had obtained positive phase...

Biotech Stock News (BCRX) (INCY)

BioCryst Pharmaceuticals (NASDAQ: BCRX) On February 8, 2016 shares of BioCryst Pharmaceuticals fell by more than 71% after the company had announced that it had...

Biotech Stock News (SYN) (CNAT)

Synthetic Biologics (NASDAQ:SYN) On February 3, 2016 shares of Synthetic Biologics fell by 14% after the company announced an update on the phase 2 clinical...

Biotech Stock News (KBIO) (RTRX) (CMRX)

Kalobios (NASDAQ:KBIO) On Tuesday December 29, 2015 Kalobios made an SEC filing whereby the company filed for Chapter 11 Bankruptcy. This does not mean that...

Biotech Stock News (AMGN) (RGLS) (BIIB) (RVNC) (AGN)

Amgen, Inc. (NASDAQ:AMGN) On October 28, 2015 Amgen had announced that it had received FDA approval for its skin cancer drug known as IMLYGIC. This...

Bristol-Myers Squibb (BMY) Stock: Spiking On Rumor Of PFE Takeover

Bristol-Myers Squibb Co (NYSE: BMY) is is experiencing a relatively strong spike in the market at the moment, and for good reason. There are...

Reviews

TradeMiner Review: Is It Worth Your While?

There are tons of trading tools out there, but none of them are quite like TradeMiner. The software doesn’t look at your...